United Therapeutics Corporation Watch

from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from 8-K 14 pages Unless This Certificate Is Presented by an Authorized Representative of the Depository Trust Company, a New York Corporation (“Dtc”), to United Therapeutics Corporation (The “Company”) or Its Agent for Registration of Transfer, Exchange or Payment, and Any Certificate Issued Is Registered in the Name of Cede & Co. or in Such Other Name as Is Requested by an Authorized Representative of Dtc (And Any Payment Is Made to Cede & Co. or to Such Other Entity as Is Requested by an Authorized Representative of Dtc), Any Transfer, Pledge or Other Use Hereof for Value or Otherwise by or to Any Person Is Wrongful Inasmuch as the Registered Owner Hereof, Cede & Co., Has an Interest Herein

from 8-K 98 pages United Therapeutics Corporation 1.0% Convertible Senior Notes Due September 15, 2016 Indenture Dated as of October 17, 2011 the Bank of New York Mellon Trust Company, N.A., as Trustee

from 8-K 61 pages First Amended and Restated Rights Agreement United Therapeutics Corporation and the Bank of New York Rights Agent Dated as of June 30, 2008

from S-3ASR 2 pages Notice: The Signature to This Assignment Must Correspond With the Name as Written Upon the Face of the Certificate, in Every Particular, Without Alteration or Enlargement, or Any Change Whatever. for Value Received Hereby Sell, Assign and Transfer Unto

from 8-K 31 pages Deutsche Bank Securities Inc. $210,000,000 Aggregate Principal Amount United Therapeutics Corporation 0.50% Convertible Senior Notes Due October 15, 2011 Resale Registration Rights Agreement Dated October 30, 2006

from 8-K 92 pages United Therapeutics Corporation 0.50% Convertible Senior Notes Due October 15, 2011 Indenture Dated as of October 30, 2006 the Bank of New York, as Trustee

from 8-K ~50 pages Rights Agreement, Dated as of December 17, 2000

from S-3 ~5 pages Stock Option Grant to Purchase

from S-3 ~10 pages Registration Rights Agreement

from S-1 ~20 pages Form of Purchase Agreement

from S-1 ~5 pages Stock Option Grant

from S-1 ~10 pages Warrant to Purchase Common Stock

from S-1 ~10 pages Form of Common Stock Purchase Agreement

from S-1 ~20 pages Registration Rights Agreement 10/30/98